CERE
Legal & General Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-73,771
| Closed | -$3.02M | – | 3433 |
|
|
2024
Q2 | $3.02M | Buy |
73,771
+1,164
| +2% | +$47.6K | ﹤0.01% | 1764 |
|
|
2024
Q1 | $3.07M | Buy |
72,607
+2,106
| +3% | +$89K | ﹤0.01% | 1746 |
|
|
2023
Q4 | $2.99M | Buy |
70,501
+10,440
| +17% | +$443K | ﹤0.01% | 1749 |
|
|
2023
Q3 | $1.31M | Buy |
60,061
+2,538
| +4% | +$55.4K | ﹤0.01% | 2081 |
|
|
2023
Q2 | $1.83M | Buy |
57,523
+4,380
| +8% | +$139K | ﹤0.01% | 1968 |
|
|
2023
Q1 | $1.3M | Buy |
53,143
+2,537
| +5% | +$61.9K | ﹤0.01% | 2064 |
|
|
2022
Q4 | $1.6M | Sell |
50,606
-541
| -1% | -$17.1K | ﹤0.01% | 1975 |
|
|
2022
Q3 | $1.45M | Buy |
51,147
+4,531
| +10% | +$128K | ﹤0.01% | 2016 |
|
|
2022
Q2 | $1.23M | Buy |
46,616
+11,882
| +34% | +$314K | ﹤0.01% | 2078 |
|
|
2022
Q1 | $1.22M | Buy |
34,734
+18,146
| +109% | +$635K | ﹤0.01% | 2173 |
|
|
2021
Q4 | $538K | Buy |
16,588
+470
| +3% | +$15.2K | ﹤0.01% | 2388 |
|
|
2021
Q3 | $475K | Buy |
16,118
+9,821
| +156% | +$289K | ﹤0.01% | 2422 |
|
|
2021
Q2 | $161K | Buy |
+6,297
| New | +$161K | ﹤0.01% | 2594 |
|